The Consumer Healthcare Products Association, or CHPA, announced Lisa Paley as Chair-elect of the CHPA Board of Directors.
Paley will assume the position of board chair in March 2023, when current CHPA board chair Michelle Goodridge, president, U.S. Self Care, Johnson & Johnson Consumer, concludes her chairmanship.
At its June meeting in Washington, CHPA also welcomed two new manufacturer members to its board of directors, including Kristin Recchiuti, CEO of Advantice Health, and Paul Wood, executive vice president, chief commercial officer and executive vice president, U.S. sales of Church & Dwight.
“I am delighted to welcome Kristin and Paul as our two newest board members,” said Scott Melville, president and CEO of CHPA, “and to congratulate Lisa on her appointment as chair-elect. Collectively, these individuals bring decades of consumer healthcare experience to our board that will help guide the association during these exciting times for self-care in the world’s largest market. I look forward to continuing to work together with each of them as we shape the industry we want for the future.”
The Consumer Healthcare Products Association is the national trade association representing the leading manufacturers and marketers of consumer healthcare products, including over-the-counter medicines, dietary supplements and consumer medical devices.
Clif Kid Zbar is expanding its organic, whole-grain energy snack bar line with a brand-new flavor addition.
The Emeryville, Calif.-based company is releasing a new blueberry muffin flavor, made to be reminiscent of a blueberry muffin straight from the oven.
Made with organic, non-GMO ingredients, the easily storable and portable bar contains 12 g of whole grains from organic oats and organic wild blueberries, the company said.
“Clif Kid is thrilled to roll out our brand new Zbar blueberry muffin flavor. It’s the perfect addition to our expansive portfolio of Zbar flavors that kids crave and parents trust,” said Valerie Van Arkel, senior brand manager at Clif Kid. “Summer break is for playing, adventuring and making priceless family memories, and Clif Kid Zbar blueberry muffin flavor is the perfect energy snack to accompany all the fun of childhood summers.”
Retailing for $5.49, Clif Kid Zbar’s blueberry muffin flavor is available at such retailers as Target, Kroger, Meijer, Wegmans, Stop & Shop, Hannaford, Hy-Vee and Raley’s, as well as online.
Wonderbelly is looking to change the way people deal with their digestive health by launching its flagship product — Wonderbelly Antacid.
The better-for-you, over-the-counter heartburn medication is formulated to treat heartburn, acid reflux and acid digestion symptoms, the company said.
Made with non-GMO and gluten-free ingredients, the antacid does not contain talc, artificial dyes or flavors, common allergens, or artificial sweeteners.
Inspired by co-founder Lucas Kraft’s journey with an eating disorder and subsequently suffering from long-lasting gut issues, his brother Noah Kraft worked alongside him to create a better, more thoughtful and tastier alternative to other products out on the market, the company said.
Available in three flavors — Strawberry Milkshake, Citrus Mint and Watermelon Mint — Wonderbelly Antacid comes in plastic-free packaging and retails for $14.99 per bottle.
ScriptAbility is now integrated with Liberty’s pharmacy management software.
This integration partnership allows Liberty’s pharmacy clients to offer accessible prescription labels more easily for their patients who are visually impaired, print impaired or have limited English proficiency.
ScriptAbility, an accessible labeling solution founded by En-Vision America, is an easy-to-use, cost-effective application that allows pharmacists to provide their patients with ScripTalk Talking Labels, ScriptView Large Print Labels, Dual Language/Translated Labels, Braille Labels and Controlled Substance Safety Labels. It also is an effective way pharmacists can ensure their patient's medication adherence and safety, the company said.
“Liberty understands patient needs,” said David Raistrick, president of En-Vision America. “We’re excited to team up with a company that knows how important label information can be to a patient. Our accessible labels remove the guesswork for patients who may have a visual or print impairment, or may not read English enough to understand the label. Liberty is ensuring that their software provides effective access to critical medication information.”
The integration allows pharmacists to quickly produce accessible labels because the ScriptAbility application can be directly accessed from the pharmacy management software. Now, instead of entering the patient’s information in the application, all the prescription and patient details will auto-populate with a few simple clicks, the company noted.
“Community pharmacies are known for delivering the best customer service and patient care,” said Jeremy Manchester, president of Liberty Software. “ScriptAbility is one more way that community pharmacies can serve and go the extra mile for patients who need help.”
Coram, CVS Specialty Infusion Services in Albany, N.Y., to close
Coram, CVS Specialty Infusion Services, in Albany, N.Y. is set to close its doors at 12 Jupiter Lane.
In a notice on June 1, the New York State Department of Labor’s Office of dislocated workers program stated that the business will be permanently closing its Albany facility, affecting a total of 70 employees.
Separations will occur during the 14-day period starting on Sept. 4, 2022. The closing date is Sept. 18, 2022, according to the NYS Department of Labor.
The department cited "economic" as the reason for the closure of the clinic.
Commenting on the closure, a CVS spokesperson provided the following statement, "As the leading health solutions company, we use our unique combination of assets to lower costs, increase access to care and improve health outcomes. We regularly review operations to focus resources as efficiently as possible and pivot when necessary to invest in healthcare services and solutions that will make the greatest impact. After a recent review, we’ve decided to focus more resources on patients who receive infusion services for specialty medications and limit the delivery of acute infusion services (such as infused antibiotics and total parenteral nutrition)."
The statement continued, "As a result, we are closing the Coram pharmacy location in Albany, New York. Patient safety and continuity of care remain of utmost importance to us. We have a comprehensive transition plan in place for any patient affected by these changes. A dedicated team will work directly with impacted patients to help them find a new provider and seamlessly transition their care."
"We will also work to help any impacted colleagues find other suitable roles within Coram or CVS Health and will provide career transition support for those who are not able to do so," CVS Health said.
The statement concluded, "The market for infusion services for specialty medications continues to see sustained growth. Coram has been a leading provider of infusion services for specialty medication for over 30 years and is uniquely positioned to continue to meet the needs of this growing market and service ourpatients in a more targeted, resourced way."